Skip to main content

Home/ Medicine & Healthcare/ Group items tagged imiquimod outcomes reactions

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
avivajazz jazzaviva

Nonsurgical Treatment Options for Basal Cell Carcinoma | Review Article | Journal of Sk... - 0 views

www.hindawi.com/...571734

BCC sBCC studies pubs outcomes efficacy therapy therapies treatment options treatments

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    Journal of Skin CancerVolume 2011 (2011), Article ID 571734, 6 pagesdoi:10.1155/2011/571734 © 2011 Mary H. Lien and Vernon K. Sondak.
avivajazz jazzaviva

Two-year interim results from a 5-year study evaluating clinical recurrence o... - 0 views

onlinelibrary.wiley.com/...abstract

BCC sBCC studies pubs outcomes efficacy therapy therapies results study clinical cream treatment

shared by avivajazz jazzaviva on 24 Jul 11 - No Cached
  • avivajazz jazzaviva on 24 Jul 11
     
    The proportion of subjects who were clinically clear at the 2-year follow-up visit was estimated to be 82.0%. Imiquimod was tolerated when applied daily, with erythema reported for all subjects participating in the study. The recurrence rate observed suggests that once daily dosing and 5×/week dosing yield similar clearance rates, but daily dosing increases local skin reactions.
1 - 3 of 3
Showing 20▼ items per page